Prostaglandin F2-alpha (PGF2α) in Vitiligo

Study of the Cutaneous Expression of Prostaglandin F2-alpha (PGF2α) in Vitiligo Patients: a Case-control Study.

study the cutaneous expression of PGF2α in vitiligo patients and compare it with normal control subjects.

Measurement of tissue levels of PGF2α in vitiligo patients and compare them with healthy controls.

Inclusion Criteria:

• Patients with non-segmental vitiligo.
• Both sexes.
• Age < 18 years old.
• New cases or cases not receiving any medications for at least 3 months ago.

Exclusion Criteria:

• Age: Patients < 18 years.
• Segmental or universal vitiligo.
• Pregnant and lactating females.